At the end of the latest market close, Xenetic Biosciences Inc. (XBIO) was valued at $2.42. In that particular session, Stock kicked-off at the price of $2.66 while reaching the peak value of $2.94 and lowest value recorded on the day was $2.56. The stock current value is $2.68.
Recently in News on January 5, 2021, Xenetic Biosciences, Inc. to Present at the H.C. Wainwright BioConnect 2021 Virtual Conference. Xenetic Biosciences, Inc. (NASDAQ:XBIO) (“Xenetic” or the “Company”), a biopharmaceutical company focused on advancing XCART™, a personalized CAR T platform technology engineered to target patient- and tumor-specific neoantigens, announced today that Jeffrey Eisenberg, Chief Executive Officer of Xenetic will present in a fireside chat at the H.C. Wainwright BioConnect 2021 Virtual Conference taking place January 11-14, 2021. You can read further details here
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Xenetic Biosciences Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $2.94 on 01/11/21, with the lowest value was $2.00 for the same time period, recorded on 01/04/21.
Xenetic Biosciences Inc. (XBIO) full year performance was 69.94%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Xenetic Biosciences Inc. shares are logging -54.10% during the 52-week period from high price, and 510.23% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.44 and $5.85.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 2265082 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Xenetic Biosciences Inc. (XBIO) recorded performance in the market was 31.62%, having the revenues showcasing 179.69% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 22.31M, as it employees total of 4 workers.
Analysts verdict on Xenetic Biosciences Inc. (XBIO)
During the last month, 0 analysts gave the Xenetic Biosciences Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 1.21, with a change in the price was noted +1.45. In a similar fashion, Xenetic Biosciences Inc. posted a movement of +118.29% for the period of last 100 days, recording 2,360,154 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for XBIO is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Xenetic Biosciences Inc. (XBIO): Technical Analysis
Raw Stochastic average of Xenetic Biosciences Inc. in the period of last 50 days is set at 37.82%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 79.60%. In the last 20 days, the company’s Stochastic %K was 52.58% and its Stochastic %D was recorded 36.76%.
Let’s take a glance in the erstwhile performances of Xenetic Biosciences Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 31.62%. Additionally, trading for the stock in the period of the last six months notably improved by 168.50%, alongside a boost of 69.94% for the period of the last 12 months. The shares increased approximately by 24.88% in the 7-day charts and went up by -15.30% in the period of the last 30 days. Common stock shares were driven by 179.69% during last recorded quarter.